Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity.

Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity.

BACKGROUND: A sensitive, phenotypic reverse transcriptase (RT)-based drug susceptibility assay for the detection of etravirine (ETR) resistance in patient isolates was developed and compared with the results from direct sequencing and ultra-deep pyrosequencing (UDPS). METHODS: Samples were obtained...

Full description

Bibliographic Details
Main Authors:	Eva Agneskog, Piotr Nowak, Catharina Maijgren Steffensson, Maria Casadellà, Marc Noguera-Julian, Roger Paredes, Clas F R Källander, Anders Sönnerborg
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4084891?pdf=render

Similar Items

Study of the physicochemical properties of the etravirine substance
by: S. A. Zolotov, et al.
Published: (2021-11-01)

Etravirine Pharmacokinetics In HIV-Infected Pregnant Women
by: Nikki Mulligan, et al.
Published: (2016-08-01)

Allergic hypersensitivity to antiretroviral drugs: etravirine, raltegravir and darunavir
by: Manuel Anastacio Sánchez-Olivas, et al.
Published: (2015-04-01)

A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine
by: Mariana Pereira, et al.
Published: (2023-10-01)

Experimental data of co-crystals of Etravirine and L-tartaric acid
by: Mikal Rekdal, et al.
Published: (2018-02-01)

The role of etravirine in the management of treatment-experienced pediatric patients with HIV
by: Osterholzer D
Published: (2013-04-01)

Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening
by: Luis Córdova-Bahena, et al.
Published: (2021-12-01)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
by: Ivanovic Jelena, et al.
Published: (2011-05-01)

Development of a practical synthesis of etravirine via a microwave-promoted amination
by: Da Feng, et al.
Published: (2018-12-01)

Efficacy and safety of darunavir and etravirine in a patient with retroviruses and multiple virologic failure
by: Claudia Bernardini, et al.
Published: (2009-09-01)

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers
by: Jan Vesterbacka, et al.
Published: (2017-07-01)

Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects
by: Mariana Pereira, et al.
Published: (2024-03-01)

Interaction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 Polymorphism.
by: Leïla Belkhir, et al.
Published: (2016-01-01)

Researching of resistance to etravirine in some HIV-1 low-level viremia strains by in-silico methods
by: Oflaz Ofcan, et al.
Published: (2023-08-01)

The results of the use of etravirine within 48 weeks in patients in Saint-Petersburg in real clinical practice
by: N. V. Sizova, et al.
Published: (2022-04-01)

Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!
by: Simon Tiberi, et al.
Published: (2018-03-01)

Probiotic effects on immunity and microbiome in HIV-1 discordant patients
by: Carlos Blázquez-Bondia, et al.
Published: (2022-12-01)

Pharmacoeconomic analysis of the etravirine compared to raltegravir in treatment HIV-infected adult patients, previously treated with antiretroviral drugs
by: Y. I. Ashikhmin, et al.
Published: (2018-05-01)

Fabrication of TPGS decorated Etravirine loaded lipidic nanocarriers as a neoteric oral bioavailability enhancer for lymphatic targeting
by: Abdul Muheem, et al.
Published: (2024-01-01)

Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population.
by: Luis F López-Cortés, et al.
Published: (2014-01-01)

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
by: Patricia Echeverría, et al.
Published: (2014-01-01)

Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study.
by: Phairote Teeranaipong, et al.
Published: (2016-01-01)

Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens
by: Valérie Potard, et al.
Published: (2018-07-01)

Phenotypic, genotypic characterisation and antimicrobial susceptibility determination of lactococcus garvieae strains
by: ALTUN S, et al.
Published: (2013-05-01)

Phenotypic and Genotypic Detection of Biofilm Formation Pseudomonas oryzihabitance and Susceptibility to Antibiotics
by: Shaimaa Obaid Hasson
Published: (2019-03-01)

Tuberculosis Phenotypic and Genotypic Drug Susceptibility Testing and Immunodiagnostics: A Review
by: Kizil A. Yusoof, et al.
Published: (2022-07-01)

Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients
by: Niccolò Riccardi MD, et al.
Published: (2019-01-01)

Correlating genotypic and phenotypic antimicrobial susceptibility testing in clinical Chlamydia trachomatis isolates
by: Arabella Touati, et al.
Published: (2023-12-01)

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights.
by: Paola Marmiroli, et al.
Published: (2017-01-01)

Phenotype, genotype, and antibiotic susceptibility of Swedish and Thai oral isolates of Staphylococcus aureus
by: Susanne Blomqvist, et al.
Published: (2015-04-01)

Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance
by: Joo Hee Lee, M.D., et al.
Published: (2019-04-01)

Phenotypic and genotypic characteristics of Escherichia coli with non-susceptibility to quinolones isolated from environmental samples on pig farms
by: Patrick Kindle, et al.
Published: (2019-02-01)

FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance.
by: Norbert Gleicher, et al.
Published: (2010-12-01)

Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.
by: Armuzzi, A, et al.
Published: (2003)

Phenotypic Antimicrobial Susceptibility and Genotypic Characterization of Clinical Ureaplasma Isolates Circulating in Shanghai, China
by: Hongxia Ma, et al.
Published: (2021-10-01)

Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study
by: Patrick K Tumwebaze, MS, et al.
Published: (2021-09-01)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
by: Leonard Rogers, et al.
Published: (2018-08-01)

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
by: Charlotte Charpentier, et al.
Published: (2013-01-01)

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa
by: Inzaule, SC, et al.
Published: (2018)

Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis
by: Thanh Truong Giang Ly, et al.
Published: (2022-01-01)